BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 22173093)

  • 1. Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: solution behavior, reactions with model proteins, antiproliferative properties.
    Maiore L; Cinellu MA; Nobili S; Landini I; Mini E; Gabbiani C; Messori L
    J Inorg Biochem; 2012 Mar; 108():123-7. PubMed ID: 22173093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, structural characterization, solution behavior, and in vitro antiproliferative properties of a series of gold complexes with 2-(2'-pyridyl)benzimidazole as ligand: comparisons of gold(III) versus gold(I) and mononuclear versus binuclear derivatives.
    Serratrice M; Cinellu MA; Maiore L; Pilo M; Zucca A; Gabbiani C; Guerri A; Landini I; Nobili S; Mini E; Messori L
    Inorg Chem; 2012 Mar; 51(5):3161-71. PubMed ID: 22339487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic studies on two dinuclear organogold(III) compounds showing appreciable antiproliferative properties and a high redox stability.
    Gabbiani C; Casini A; Kelter G; Cocco F; Cinellu MA; Fiebig HH; Messori L
    Metallomics; 2011 Dec; 3(12):1318-23. PubMed ID: 21887452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synthesis, chemical and biological properties of dichlorido(azpy)gold(III) chloride (azpy=2-(phenylazo)pyridine) and the gold-induced conversion of the azpy ligand to the chloride of the novel tricyclic pyrido[2,1-c][1,2,4]benzotriazin-11-ium cation.
    Garza-Ortiz A; den Dulk H; Brouwer J; Kooijman H; Spek AL; Reedijk J
    J Inorg Biochem; 2007 Nov; 101(11-12):1922-30. PubMed ID: 17637477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand.
    Maiore L; Cinellu MA; Michelucci E; Moneti G; Nobili S; Landini I; Mini E; Guerri A; Gabbiani C; Messori L
    J Inorg Biochem; 2011 Mar; 105(3):348-55. PubMed ID: 21421122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterisation and biological properties of gold(III) compounds with modified bipyridine and bipyridylamine ligands.
    Casini A; Diawara MC; Scopelliti R; Zakeeruddin SM; Grätzel M; Dyson PJ
    Dalton Trans; 2010 Mar; 39(9):2239-45. PubMed ID: 20162197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
    Sun RW; Li CK; Ma DL; Yan JJ; Lok CN; Leung CH; Zhu N; Che CM
    Chemistry; 2010 Mar; 16(10):3097-113. PubMed ID: 20162647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization and cytotoxicity of the gold(III) complexes of 4,5-dihydropyrazole-1-carbothioamide derivatives.
    Wang S; Shao W; Li H; Liu C; Wang K; Zhang J
    Eur J Med Chem; 2011 May; 46(5):1914-8. PubMed ID: 21392862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and solution chemistry, antiproliferative effects, and DNA and protein binding properties of a series of dinuclear gold(III) compounds with bipyridyl ligands.
    Casini A; Cinellu MA; Minghetti G; Gabbiani C; Coronnello M; Mini E; Messori L
    J Med Chem; 2006 Sep; 49(18):5524-31. PubMed ID: 16942025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships in cytotoxic Au(I)/Au(III) complexes derived from 2-(2'-pyridyl)benzimidazole.
    Maiore L; Aragoni MC; Deiana C; Cinellu MA; Isaia F; Lippolis V; Pintus A; Serratrice M; Arca M
    Inorg Chem; 2014 Apr; 53(8):4068-80. PubMed ID: 24679072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming cisplatin resistance using gold(III) mimics: anticancer activity of novel gold(III) polypyridyl complexes.
    Palanichamy K; Sreejayan N; Ontko AC
    J Inorg Biochem; 2012 Jan; 106(1):32-42. PubMed ID: 22112837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design of gold(III)-dithiocarbamato peptidomimetics for the targeted anticancer chemotherapy.
    Kouodom MN; Boscutti G; Celegato M; Crisma M; Sitran S; Aldinucci D; Formaggio F; Ronconi L; Fregona D
    J Inorg Biochem; 2012 Dec; 117():248-60. PubMed ID: 22877925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of gold(I) and gold(III) complexes by pyridil bis{3-hexamethylene-iminylthiosemicarbazone}: spectroscopic, structural and computational study.
    Castiñeiras A; Dehnen S; Fuchs A; García-Santos I; Sevillano P
    Dalton Trans; 2009 Apr; (15):2731-9. PubMed ID: 19333496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organogold(III) supramolecular polymers for anticancer treatment.
    Zhang JJ; Lu W; Sun RW; Che CM
    Angew Chem Int Ed Engl; 2012 May; 51(20):4882-6. PubMed ID: 22473661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, structural characterisation and anti-proliferative activity of NHC gold amino acid and peptide conjugates.
    Lemke J; Pinto A; Niehoff P; Vasylyeva V; Metzler-Nolte N
    Dalton Trans; 2009 Sep; (35):7063-70. PubMed ID: 20449149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor properties of five-coordinate gold(III) complexes bearing substituted polypyridyl ligands.
    Sanghvi CD; Olsen PM; Elix C; Peng SB; Wang D; Chen ZG; Shin DM; Hardcastle KI; MacBeth CE; Eichler JF
    J Inorg Biochem; 2013 Nov; 128():68-76. PubMed ID: 23948576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic effects of gold(III) complexes on established human tumor cell lines sensitive and resistant to cisplatin.
    Calamai P; Carotti S; Guerri A; Mazzei T; Messori L; Mini E; Orioli P; Speroni GP
    Anticancer Drug Des; 1998 Jan; 13(1):67-80. PubMed ID: 9474243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organogold(III) compounds as experimental anticancer agents: chemical and biological profiles.
    Massai L; Cirri D; Michelucci E; Bartoli G; Guerri A; Cinellu MA; Cocco F; Gabbiani C; Messori L
    Biometals; 2016 Oct; 29(5):863-72. PubMed ID: 27476157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-bite bis(phosphite) ligand containing mesocyclic thioether moieties: synthesis, reactivity, group 11 (Cu(I), Au(I)) metal complexes and anticancer activity studies on a human cervical cancer (HeLa) cell line.
    Suresh D; Balakrishna MS; Rathinasamy K; Panda D; Mague JT
    Dalton Trans; 2008 May; (17):2285-92. PubMed ID: 18414753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gold(III) dithiocarbamate derivatives for the treatment of cancer: solution chemistry, DNA binding, and hemolytic properties.
    Ronconi L; Marzano C; Zanello P; Corsini M; Miolo G; Maccà C; Trevisan A; Fregona D
    J Med Chem; 2006 Mar; 49(5):1648-57. PubMed ID: 16509581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.